Comparison Between Oral and Enema of Chloral Hydrate
Primary Purpose
Congenital Cataract
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
oral chloral hydrate
enema chloral hydrate
Sponsored by
About this trial
This is an interventional other trial for Congenital Cataract focused on measuring pediatric ophthalmic examination, chloral hydrate, Effects Comparison
Eligibility Criteria
Inclusion Criteria:
- diagnosed with congenital cataract aged from 3 to 36 months weight from 5 to 15 kg with American Society of Anesthesiologists (ASA) physical status 1-2
Exclusion Criteria:
- with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months recent pneumonia exacerbation of asthma, bronchitis and upper respiratory tract infection bradycardia, and facial abnormalities, allergy to chloral hydrate, weight <2 or >20 kg .
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
oral group
enema group
Arm Description
Outcomes
Primary Outcome Measures
Demography (age, sex, weight, laterality and medical history)
The demography of cataract and healthy children were recorded by using a semi-structured questionnaire
Secondary Outcome Measures
Side effect
record the following symptom: Vomit after administration、Cough、SpO2 < 95%、SpO2 < 90%、New vomiting、Resume normal activity over 8 hour、Poor appetite、Altered bowel habit
the time of Sleepiness:Onset time (min)
the time of Sleepiness:Duration of examination (min)
the time of Sleepiness:Recovery time (min)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03242629
Brief Title
Comparison Between Oral and Enema of Chloral Hydrate
Official Title
Effects Comparison Between Oral and Enema of Chloral Hydrate in Pediatric Ophthalmic Examination
Study Type
Interventional
2. Study Status
Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
July 2017 (Actual)
Study Completion Date
July 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sun Yat-sen University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).
Detailed Description
To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).One hundred and twenty children aged from 3 to 36 months (5-15 kg) scheduled to ophthalmic examinations were randomly sedated by oral chloral hydrate(80 mg×kg-1, n = 60) or enema chloral hydrate(80 mg×kg-1, n = 60). The primary endpoint was successful sedation to complete the examinations including slit-lamp photography, tonometry, anterior segment analysis, and refractive error inspection. The secondary endpoints included onset time, duration of examination, recovery time, discharge time, any side effects during examination, and within 48 h after discharge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Cataract
Keywords
pediatric ophthalmic examination, chloral hydrate, Effects Comparison
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
oral group
Arm Type
Active Comparator
Arm Title
enema group
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
oral chloral hydrate
Intervention Description
Chloral hydrate syrup was available in a concentration of 100 mg×ml-1.The children assigned to receive 0.8 ml×kg-1 of chloral hydrate (80 mg×kg-1) by oral.
Intervention Type
Drug
Intervention Name(s)
enema chloral hydrate
Intervention Description
Chloral hydrate syrup was available in a concentration of 100 mg×ml-1 at our hospital.The children assigned to receive 0.8 ml×kg-1 of chloral hydrate (80 mg×kg-1) by enema.
Primary Outcome Measure Information:
Title
Demography (age, sex, weight, laterality and medical history)
Description
The demography of cataract and healthy children were recorded by using a semi-structured questionnaire
Time Frame
baseline
Secondary Outcome Measure Information:
Title
Side effect
Description
record the following symptom: Vomit after administration、Cough、SpO2 < 95%、SpO2 < 90%、New vomiting、Resume normal activity over 8 hour、Poor appetite、Altered bowel habit
Time Frame
the following 48 hour after using the drug
Title
the time of Sleepiness:Onset time (min)
Time Frame
baseline
Title
the time of Sleepiness:Duration of examination (min)
Time Frame
baseline
Title
the time of Sleepiness:Recovery time (min)
Time Frame
baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
36 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosed with congenital cataract aged from 3 to 36 months weight from 5 to 15 kg with American Society of Anesthesiologists (ASA) physical status 1-2
Exclusion Criteria:
with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months recent pneumonia exacerbation of asthma, bronchitis and upper respiratory tract infection bradycardia, and facial abnormalities, allergy to chloral hydrate, weight <2 or >20 kg .
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Haotian Lin, M.D,Ph.D
Organizational Affiliation
Zhongshan Ophthalmic Center, Sun Yat-sen University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Comparison Between Oral and Enema of Chloral Hydrate
We'll reach out to this number within 24 hrs